Arun, Banu http://orcid.org/0000-0002-5475-8509
Couch, Fergus J.
Abraham, Jean
Tung, Nadine
Fasching, Peter A. http://orcid.org/0000-0003-4885-8471
Funding for this research was provided by:
AstraZeneca
Merck & Co., Inc. | Merck Sharp and Dohme
Merck & Co., Inc. | Merck Sharp and Dohme
Merck & Co., Inc. | Merck Sharp and Dohme
Merck & Co., Inc. | Merck Sharp and Dohme
Merck & Co., Inc. | Merck Sharp and Dohme
Article History
Received: 5 April 2024
Revised: 9 August 2024
Accepted: 13 August 2024
First Online: 30 August 2024
Competing interests
: BA has received research funding from AstraZeneca. FJC has received research funding from the Breast Cancer Research Foundation, GRAIL and the NIH, has received an honorarium from Ambry Genetics, and has received consulting fees from AstraZeneca. JA has received research funding, consulting fees, as well as honoraria and support for meeting attendance from AstraZeneca. NT has received research funding from AstraZeneca and consulting fees from AstraZeneca and Merck Sharp & Dohme. PAF has received research funding from Biontech, Cepheid and Pfizer, has attended advisory boards for, and received honoraria and consulting fees from, Agendia, AstraZeneca, Daiichi-Sankyo, Eisai, Gilead, Lilly, Merck Sharp & Dohme, Mylan, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi Aventis and SeaGen.